First-Line Topical Treatment for Acanthosis Nigricans Skin Lesions

This protocol covers the first-line topical management of acanthosis nigricans (AN) skin lesions, with clearly defined clearance goals. The approach involves an established class of topical agents, and the full structured regimen specifies the options appropriate for each patient situation.

Treatment Approach

Topical retinoid therapy is the recognised first-line treatment class for AN skin lesions. The full protocol outlines multiple topical options — including combination regimens and alternative agents — as well as non-medication approaches for relevant patient profiles. The complete selection and sequencing details are available in the structured regimen.

Specific agents, combinations, and non-medication options are detailed in the full protocol — not shown here.

Clinical Goals

Total clearance of acanthosis nigricans skin lesions at 16 weeks; improvement of hyperkeratosis.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.2147/CCID.S137527

Topical retinoids are considered one of the first-line treatment options for AN.
For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate.
Of the 30 patients, 24 (80%) showed total clearance at 16 weeks.

View source ↗